Lundbeck to showcase new neurology data at the American Academy of Neurology Annual Meeting

Seven abstracts represent data across migraine, childhood-onset epilepsy and multiple system atrophy (MSA), highlighting Lundbeck's biology-driven approach to developing treatments for serious brain diseases Oral presentation of new Phase 1 safety and tolerability data for bocunebart (Lu...